ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 584,85
-0,63%
Dow Jones
40 829,48
1,54%
DAX
18 530,33
-0,38%
Brent Oil
83,655
-0,81%
Bitcoin
64 448,48
-0,62%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
23/03/201615h55Business WireTeva Announces FDA Approval of CINQAIR® (reslizumab) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
22/03/201613h13Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
22/03/201613h00Business WireTeva Announces Launch of Generic Campral® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/03/201617h10Dow Jones NewsTeva Acquisition of Allergan Generics Unit Delayed--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
15/03/201616h30Dow Jones NewsTeva Acquisition of Allergan Generics Unit DelayedNYSE:TEVATeva Pharmaceutical Industries Ltd
11/03/201617h30Business WireTeva to Present at the Barclays Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h13Dow Jones NewsEU Approves Teva Takeover of Allergan Generics Unit -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h10Dow Jones NewsEU Approves Teva Takeover of Allergan Generics UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h07Dow Jones NewsEU Approves Teva's Takeover of Allergan's Generics UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201615h02Business WireTeva Receives European Commission Approval for the Allergan Generics AcquisitionNYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201621h54Dow Jones NewsTeva Deal for Allergan Generics Unit Expected to Get Europe OK -ReutersNYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201619h00Business WireTeva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201617h33Business WireTeva Completes Generic Pulmicort® Respules Portfolio with the Launch of Third Strength in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
03/03/201615h10Business WireTeva Completes Acquisition of RimsaNYSE:TEVATeva Pharmaceutical Industries Ltd
03/03/201614h00Business WireTeva to Present New Respiratory Data at the 2016 Academy of Allergy, Asthma and Immunology Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201617h07Business WireTeva to Present at the Cowen & Company 36th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201615h00PR Newswire (Canada)Teva Canada annonce le lancement de la solution pour inhalation (Pr)Teva-Tobramycin, un substitut générique de (Pr)Tobi®NYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201615h00PR Newswire (Canada)Teva Canada Announces the Launch of (Pr)Teva-Tobramycin Inhalation Solution, a Generic of (Pr)Tobi®NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201612h00Business WireTeva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global BrandNYSE:TEVATeva Pharmaceutical Industries Ltd
22/02/201615h42Dow Jones NewsAllergan Tops Expectations on Botox Sales -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/201616h20Dow Jones NewsLilly: U.K. Court Rules in Opponent's Favor on Alimta PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/201615h32Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:TEVATeva Pharmaceutical Industries Ltd
11/02/201623h00Business WireTeva Files 2015 Annual Report on Form 20-FNYSE:TEVATeva Pharmaceutical Industries Ltd
11/02/201615h42Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
11/02/201614h50Dow Jones NewsTeva Pharmaceuticals Reports Sales DeclineNYSE:TEVATeva Pharmaceutical Industries Ltd
11/02/201613h00Business WireTeva Reports Full Year 2015 and Fourth Quarter Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/02/201614h00Business WireTeva and AbCellera Enter Into Agreement to Discover Rare Monoclonal AntibodiesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/201617h16Business WireTeva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine hydrochloride) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/201614h00Business WireTeva to Report Fourth Quarter 2015 Financial Results on February 11, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
25/01/201614h30Business WireTeva Releases Innovation and Social Responsibility HighlightsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
STRC
Palladyne AI
COIN
FETUSD
Fetch
LSE
CPP
Cppgroup
NASDAQ
SNDL
Sundial Growers
AMEX
OBLG
Oblong
LSE
0H1I
Powershares Us Hy Fall A...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés